1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 630 F.Supp.3d
  5. 630 F.Supp.3d 241 (2022)
 

IN RE RANBAXY GENERIC DRUG APP. ANTITRUST LIT.

MDL No. 19-md-02878-NMG.

630 F.Supp.3d 241 (2022)

IN RE: RANBAXY GENERIC DRUG APPLICATION ANTITRUST LITIGATION.

United States District Court, D. Massachusetts.

Signed September 19, 2022.

MEMORANDUM & ORDER

This multi-district litigation involves five actions that were centralized in this Court and divided into two plaintiff classes against Ranbaxy Inc. and Sun Pharmaceutical Industries Limited (collectively, "Ranbaxy" or "defendants...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases